Section one: Contracting authority
one.1) Name and addresses
Queen's University Belfast
University Road
Belfast
BT7 1NN
Contact
Mrs Gillian Wasson
Telephone
+44 2890973026
Country
United Kingdom
NUTS code
UKN - Northern Ireland
Internet address(es)
Main address
https://www.qub.ac.uk/directorates/FinanceDirectorate/visitors/procurement/
Buyer's address
https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home
Tenders or requests to participate must be submitted to the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Education
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
QUB/2150/21 Supply, Delivery, Installation, Commissioning, Maintenance and purchase of consumables for a Microfluidics Cell System
Reference number
QUB/2150/21
two.1.2) Main CPV code
- 38636000 - Specialist optical instruments
two.1.3) Type of contract
Supplies
two.1.4) Short description
The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT) is an industry-focused partnership of Life and Health Science (LHS) companies and Academia, aligned to NI Health and Economy strategies. By addressing critical commercial gaps, the Consortium's aim is to transform the productivity of each Commercial Partner and the broader LHS sector in NI. NIPBT will deploy the grant funding to collaboratively develop Research and Development capabilities that industry partners require. Queen’s is leading the NIPBT and as such is tasked with procuring and overseeing the installation of equipment to perform microfluidic single cell analysis within Health Sciences Building, Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7AE.
two.1.5) Estimated total value
Value excluding VAT: £2,000,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
two.2.3) Place of performance
NUTS codes
- UKN - Northern Ireland
Main site or place of performance
Belfast
two.2.4) Description of the procurement
The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT) is an industry-focused partnership of Life and Health Science (LHS) companies and Academia, aligned to NI Health and Economy strategies. By addressing critical commercial gaps, the Consortium's aim is to transform the productivity of each Commercial Partner and the broader LHS sector in NI. NIPBT will deploy the grant funding to collaboratively develop R&D capabilities that industry partners require. Queen’s is leading the NIPBT and as such is tasked with procuring and overseeing the installation of equipment to perform microfluidic single cell analysis.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £2,000,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
60
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
The contract includes the option for maintenance, servicing and the purchase of consumables to be extended until the end of useful life of the equipment.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
three.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
Accelerated procedure
Justification:
The funding body associated with this procurement requires that delivery and invoicing take place by 31 March 2022. Accelerated procedure is necessary to ensure suppliers can offer equipment lead times that fall within the prescribed window of funding.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
19 November 2021
Local time
4:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.7) Conditions for opening of tenders
Date
19 November 2021
Local time
4:30pm
Place
Belfast
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.2) Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
six.4) Procedures for review
six.4.1) Review body
Queen's University Belfast
University Road
Belfast
BT7 1NN
Country
United Kingdom
Internet address
https://www.qub.ac.uk/directorates/FinanceDirectorate/visitors/procurement/
six.4.3) Review procedure
Precise information on deadline(s) for review procedures
This authority will incorporate a standstill period at the point information on the award of the contract is communicated to Tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the contract is entered into.The Public Contract Regulations 2015 (SI 2015/102) provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England, Wales and Northern Ireland).